BIOCON - IntraDay Trade Analysis with Live Signals

Last Updated Time : 19 Sept 25, 2:16 pm

IntraDay Trade Rating: 3.0

📊 Intraday Trading Analysis for BIOCON

✅ Is BIOCON a Good Intraday Candidate?

Cautiously tradable. BIOCON shows short-term technical stability but is weighed down by weak fundamentals and bearish momentum

Momentum Indicators

RSI at 55.2: Neutral to mildly bullish — no strong directional bias.

MACD at -0.86: Negative crossover — signals fading momentum.

Price Action

Trading above DMA50 (₹363) and DMA200 (₹352) — mildly bullish structure.

Current price (₹368) is far below 52-week high (₹406) — recovery potential exists but not confirmed.

Volume

Current volume (94.3 lakh) is significantly higher than 1-week average (34.8 lakh) — strong liquidity, possibly driven by speculative interest.

Fundamentals

ROCE (2.09%) and ROE (0.40%) — extremely weak efficiency.

PAT turned negative this quarter (₹–8.3 Cr.) vs ₹21.2 Cr. — sharp earnings reversal.

P/E (3,939) and PEG (–211) — severely overvalued.

EPS of ₹5.01 — poor earnings quality.

DII holding increased (+7.10%) — institutional support is a positive.

🎯 Optimal Buy Price (Fresh Entry)

Buy Zone: ₹364–₹366

Entry near DMA50 with tight stop-loss, only if price stabilizes and MACD flattens.

📈 Profit-Taking & 📉 Loss Protection

Target 1: ₹373 (minor resistance)

Target 2: ₹378 (next breakout level)

Stop-Loss: ₹360 (below DMA50 and intraday support)

🕒 If You Already Hold Today

Exit on Strength

If price breaks ₹373 with rising volume and RSI > 58, trail stop-loss to ₹368 and aim for ₹378.

Exit on Weakness

If price dips below ₹360 and MACD remains negative, consider exiting to protect gains.

⚠️ Final Take

BIOCON is a speculative intraday candidate today. While volume is strong and price is above key averages, fundamentals are weak and momentum is fading. Best suited for disciplined scalping with tight risk controls.

Want to compare this with other pharma or biotech stocks for stronger setups?

Edit in a page